Miquel Vila Bover
  • Biography
  • Miquel Vila is the group leader of the Neurodegenerative Diseases Research Group at the Vall d’Hebron Research Institute (Barcelona, Spain), devoted to the elucidation of the molecular mechanisms of neurodegeneration in Parkinson’s disease. To date, Dr. Vila has co-authored over 87 professional publications, with an H-index of 49 and more than 11,000 citations. He is listed among the Top 50 Cited Parkinson’s disease (PD) Investigators worldwide 2001-10 and Top 50 PD investigators worldwide with a most broad-impact citations (Sorensen & Weedon, 2011).
    Miquel Vila received his medical degree from the University of Barcelona Medical School (Barcelona, Spain) in 1993. He then moved to the laboratory of Experimental Neurology and Therapeutics, INSERM U289 (Prof. Yves Agid) at the Salpêtrière Hospital in Paris (France), where he obtained his Master degree (D.E.A.) and Ph.D. in Neuroscience from the University of Paris VI (Pierre et Marie Curie), under the supervision of Dr. Etienne Hirsch. His Ph.D. work was devoted to the study of the functional consequences of dopaminergic neurodegeneration on the functioning of the basal ganglia. From 1998 to 2001, he worked as a postdoctoral researcher at the laboratory of Dr. Serge Przedborski at the Department of Neurology, Movement Disorders Division, at Columbia University (New York, USA), focusing on the molecular mechanisms of neuronal death in Parkinson's disease. In 2001 he obtained a tenure-track position as Assistant Professor of Neurology at Columbia University to continue his work in the USA. In 2006, he moved back to Barcelona as a Professor at ICREA (Catalan Institution for Research and Advanced Studies) to develop a new research lab on neurodegeneration at the Vall d’Hebron Research Institute, thanks to the support from the European Commission’s Marie Curie Excellence Grants program. In addition, he holds positions as Associate Professor at the Department of Biochemistry and Molecular Biology of the Autonomous University of Barcelona (UAB) and as Principal Investigator of the Spanish Network of Excellence on Neurodegenerative Diseases (CIBERNED).
  • Research groups
  • Neurodegenerative Diseases
  • More information
  • Scopus Author ID: 7103149902



2022 Universitat Autònoma de Barcelona